Scientists Develop Experimental Obesity Drugs Targeting Mitochondrial Energy Production to Burn Calories
Researchers at the University of Technology Sydney have developed experimental drugs called 'mitochondrial uncouplers' that target the cell's energy production process. These molecules make cells burn energy less efficiently, releasing fuel as heat instead of converting it into ATP (chemical energy). This process forces cells to consume more fats to meet their energy needs, offering a potential new treatment for obesity. Unlike older, lethal versions of such compounds, these new 'mild' uncouplers are designed to be safer, reducing oxidative stress and potentially offering benefits for metabolic health and neurodegenerative diseases like dementia.
Key Points
- Mitochondrial uncouplers disrupt the production of ATP, triggering cells to burn more fat for energy.
- The research focuses on 'mild' uncouplers to avoid the lethal overheating associated with earlier versions of these compounds.
- These drugs could potentially treat obesity, improve metabolic health, and provide anti-aging effects.
- The study was published in the journal 'Chemical Science'.
Exam Facts
- Mitochondria are known as the 'powerhouses' of the cell, converting food into ATP (adenosine triphosphate).
- The research was led by Tristan Rawling at the University of Technology Sydney.
Read it. Retain it. Recall it.
Get spaced-repetition flashcards, daily quizzes and offline access — free on Android.